FBIO
Fortress Biotech Inc Pref Series A
NASDAQ: FBIOP · HEALTHCARE · BIOTECHNOLOGY
$14.39
-0.21% today
Updated 2026-04-30
Market cap
$76.49M
P/E ratio
—
P/S ratio
1.21x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$6 – $15
Volume
0.0M
Fortress Biotech Inc Pref Series A (FBIOP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $863000.00 | $16.48M | $187.58M | $26.88M | $36.63M | $45.60M | $68.79M | $75.74M | $84.51M | $57.67M | $63.26M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | +1809.6% | +1038.3% | -85.7% | +36.3% | +24.5% | +50.9% | +10.1% | +11.6% | -31.8% | +9.7% |
| Cost of revenue | — | — | — | $22000.00 | — | — | — | $0.00 | $11.35M | $161.20M | $6.13M | $10.53M | $14.59M | $32.08M | $30.77M | $22.89M | $20.88M | $20.92M |
| Gross profit | — | — | — | — | — | — | — | $863000.00 | $5.13M | $26.38M | $20.76M | $26.10M | $31.00M | $36.71M | $44.97M | $61.62M | $36.80M | $42.34M |
| Gross margin | — | — | — | — | — | — | — | 100.0% | 31.1% | 14.1% | 77.2% | 71.2% | 68.0% | 53.4% | 59.4% | 72.9% | 63.8% | 66.9% |
| R&D | $2.90M | $2.27M | $8.34M | $29.29M | $18.51M | $25.68M | $10.24M | $29.81M | $35.13M | $52.49M | $87.38M | $81.33M | $64.11M | $128.87M | $134.88M | $106.07M | $56.88M | $11.90M |
| SG&A | — | — | $900000.00 | $5.75M | $8.66M | $10.10M | $10.41M | $21.58M | $31.11M | $73.02M | $53.37M | $55.59M | $61.17M | $86.84M | $113.66M | $99.71M | $87.73M | $96.40M |
| Operating income | $-3.24M | $-2.61M | $-9.24M | $-35.04M | $-27.18M | $-35.78M | $-20.65M | $-50.53M | $-65.71M | $-89.80M | $-120.00M | $-110.82M | $-94.27M | $-188.54M | $-203.56M | $-142.34M | $-110.38M | $-70.22M |
| Operating margin | — | — | — | — | — | — | — | -5855.3% | -398.7% | -47.9% | -446.4% | -302.5% | -206.7% | -274.1% | -268.8% | -168.4% | -191.4% | -111.0% |
| EBITDA | $-3.23M | $-2.61M | $-8.45M | $-35.04M | $-27.18M | $-35.76M | $-20.63M | $-52.37M | $-66.87M | $-88.57M | $-118.40M | $-88.48M | $-87.82M | $-146.17M | $-193.69M | $-135.72M | $-104.49M | $-20.16M |
| EBITDA margin | — | — | — | — | — | — | — | -6068.7% | -405.8% | -47.2% | -440.4% | -241.6% | -192.6% | -212.5% | -255.7% | -160.6% | -181.2% | -31.9% |
| EBIT | — | — | $-8.45M | $-36.45M | $-27.18M | $-35.78M | $-20.65M | $-52.40M | $-67.60M | $-89.83M | $-120.46M | $-93.13M | $-93.14M | $-152.96M | $-203.05M | $-141.72M | $-108.95M | $-24.83M |
| Interest expense | $573000.00 | $1.05M | $313000.00 | $74000.00 | $670000.00 | $1.90M | $1.34M | $1.48M | $3.69M | $7.69M | $10.34M | $11.85M | $15.33M | $15.31M | $13.64M | $12.52M | $9.93M | $8.71M |
| Income tax | — | — | $1.05M | $-91000.00 | $233000.00 | $525000.00 | $1.31M | $-4.00M | $-12.51M | $1.51M | $-463000.00 | $-49.85M | $136000.00 | $473000.00 | $449000.00 | $521000.00 | $312000.00 | — |
| Effective tax rate | 0.0% | 0.0% | -11.7% | 0.2% | -0.9% | -1.4% | -6.9% | 7.6% | 18.5% | -2.3% | 0.5% | 55.5% | -0.3% | -0.7% | -0.5% | -0.9% | -0.7% | 0.0% |
| Net income | $-3.80M | $-3.67M | $-9.98M | $-36.36M | $-27.61M | $-37.16M | $-20.39M | $-48.43M | $-55.09M | $-66.88M | $-84.15M | $-39.96M | $-46.53M | $-64.70M | $-86.58M | $-60.64M | $-46.00M | $6.82M |
| Net income growth (YoY) | — | +3.5% | -172.3% | -264.3% | +24.1% | -34.6% | +45.1% | -137.6% | -13.8% | -21.4% | -25.8% | +52.5% | -16.4% | -39.1% | -33.8% | +30.0% | +24.1% | +114.8% |
| Profit margin | — | — | — | — | — | — | — | -5611.6% | -334.3% | -35.7% | -313.0% | -109.1% | -102.0% | -94.1% | -114.3% | -71.7% | -79.8% | 10.8% |